Researchers mass produce reprogrammed T cells that target cancer cells

(Phys.org) —A team of researchers at the Memorial Sloan-Kettering Cancer Center has developed a method for mass producing T cells that have been reprogrammed using stem cell technology to target and destroy cancerous tumors. In their paper published in the journal Nature Biotechnology, the team describes how they collected isolated T cells, reprogrammed them into stem cells, added a gene marker, than reprogrammed them back into T cells that are able to target cells in cancerous tumors.

Read the whole article on Physorg

More from Physorg